acquired at ten clinical sites in the United States. Institutional review board
approval was received at each site. Research biopsy cores were collected from
consented subjects either as an additional biopsy pass obtained specifically for
research during a clinically indicated biopsy procedure (nine sites), or as a
portion of a biopsy specimen acquired for diagnostic pathology during a
clinically-indicated biopsy procedure (one site). Control kidney samples were
obtained at a single site by biopsy of a living donor kidney after removal from
the donor and before implantation in the recipient.
After acquisition, kidney biopsy samples were placed into HypoThermosol
FRS preservation solution for 10–30min on ice and then transferred to a
cryovial containing 1ml CryoStor CS10 cryopreservation medium (BioLife
Solutions). The cryovial was incubated on ice for 20–30min and was then
placed in a Mr. Frosty freezing container (Nalgene, catalog no.
5100–0001) and transferred to a −80°C freezer overnight.
Cryopreserved samples were then stored in liquid nitrogen and shipped on dry ice
to the central processing site, where they were stored in liquid nitrogen until
processing.